Israel’s Madrigal Mental Care announced today a nasal spray featuring psychedelic mushrooms.
The Beersheba-based biopharmaceutical company’s spray emits nanoparticles that encapsulate psilocybin, which is found in psychedelic mushrooms ("shrooms"). The spray also contains the pain drug ketamine, the recreational drug MDMA (molly or ecstasy) and other substances. The spray is designed to treat post-traumatic stress disorder (PTSD), anxiety, depression and other issues, Madrigal said in a press release.